Physician profile
Alexander Raines
NPI 1184850539
$35,517.88
in general payments reported to CMS, 2019-2025
9 companies · $4,590 in 2025
The $4,590 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $626 · 2021: $838 · 2022: $2,926 · 2023: $5,678 · 2024: $11K · 2025: $4,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $17K · Travel and Lodging: $3,827 · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,750.00 |
| Travel and Lodging | $3,826.60 |
| Food and Beverage | $306.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $35,072.34 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $160.39 | 2021 | |
| Covidien LP | $72.83 | 2019 | |
| Ethicon US, LLC | $62.42 | 2023-2024 | Echelon Flex, Dermabond Prineo, Stratafix |
| Smith+Nephew, INC. | $38.52 | 2025 | Stravix |
| Stryker Corporation | $37.60 | 2023 | Spy-Phi System |
| Tas Medical, INC. | $32.80 | 2024 | |
| Merck Sharp & Dohme LLC | $25.55 | 2019-2025 | Bridion |
| Vertex Pharmaceuticals Incorporated | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Raines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.